Olema Pharmaceuticals (OLMA) Proxy filing summary

Executive summary

• The annual meeting will be held virtually on June 17, 2026, with voting on director elections, executive compensation, and auditor ratification.

• Stockholders of record as of April 23, 2026, are eligible to vote, with 87,346,132 shares outstanding.

• Proxy materials are available online, and voting can be done electronically, by phone, or by mail.

Voting matters and shareholder proposals

• Four Class III directors are nominated for election to serve until 2029.

• Advisory vote on executive compensation (say-on-pay) is scheduled.

• Ratification of Ernst & Young LLP as independent auditor for 2026 is up for vote.

• Shareholder proposals for the 2027 meeting must be submitted by January 1, 2027.

Board of directors and corporate governance

• The board consists of eleven directors, with a majority classified as independent under Nasdaq standards.

• Board leadership is separated between the Chairperson and CEO.

• Committees include Audit, Compensation, Nominating and Corporate Governance, and Science and Technology.

• Directors are selected based on experience, diversity, and independence.